Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

Literature DB >> 8466274

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

P C Ng¹.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Dexamethasone

Year: 1993 PMID： 8466274 PMCID： PMC1590377 DOI： 10.1136/adc.68.3_spec_no.330

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

× No keyword cloud information.

33 in total

1. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.

Authors: N J Kazzi; Y W Brans; R L Poland
Journal: Pediatrics Date: 1990-11 Impact factor: 7.124

2. Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia.

Authors: P C Ng; K G Brownlee; E J Kelly; M J Henderson; M Smith; P R Dear
Journal: Arch Dis Child Date: 1992-10 Impact factor: 3.791

Review 3. Bronchopulmonary dysplasia: then and now.

Authors: W H Northway
Journal: Arch Dis Child Date: 1990-10 Impact factor: 3.791

4. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia.

Authors: P C Ng; M E Blackburn; K G Brownlee; J M Buckler; P R Dear
Journal: Arch Dis Child Date: 1989-12 Impact factor: 3.791

5. Renal calcification after dexamethasone in infants with bronchopulmonary dysplasia.

Authors: M D Kamitsuka; D Peloquin
Journal: Lancet Date: 1991-03-09 Impact factor: 79.321

6. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.

Authors: P C Ng; K G Brownlee; P R Dear
Journal: Arch Dis Child Date: 1991-10 Impact factor: 3.791

7. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.

Authors: T F Yeh; J A Torre; A Rastogi; M A Anyebuno; R S Pildes
Journal: J Pediatr Date: 1990-08 Impact factor: 4.406

8. Some physiological, biochemical, and behavioral consequences of neonatal hormone administration: cortisol and thyroxine.

Authors: S Schapiro
Journal: Gen Comp Endocrinol Date: 1968-04 Impact factor: 2.822

9. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.

Authors: S H Murch; T T MacDonald; C B Wood; K L Costeloe
Journal: Thorax Date: 1992-01 Impact factor: 9.139

10. Catabolic effect of dexamethasone in the preterm baby.

Authors: K G Brownlee; P C Ng; M J Henderson; M Smith; J H Green; P R Dear
Journal: Arch Dis Child Date: 1992-01 Impact factor: 3.791

30 in total

Review 1. The fetal and neonatal hypothalamic-pituitary-adrenal axis.

Authors: P C Ng
Journal: Arch Dis Child Fetal Neonatal Ed Date: 2000-05 Impact factor: 5.747

Review 2. Current perspectives on the drug treatment of neonatal respiratory distress syndrome.

Authors: D G Sweet; H L Halliday
Journal: Paediatr Drugs Date: 1999 Jan-Mar Impact factor: 3.022

Review 3. A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors: D G Sweet; H L Halliday
Journal: Drug Saf Date: 2000-05 Impact factor: 5.606

4. Changes in markers of bone metabolism during dexamethasone treatment for chronic lung disease in preterm infants.

Authors: P C Ng; C W K Lam; G W K Wong; C H Lee; P S Cheng; T F Fok; I H S Chan; E Wong; K Cheung; S Y Lee
Journal: Arch Dis Child Fetal Neonatal Ed Date: 2002-01 Impact factor: 5.747

5. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors: K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal: Eur J Pediatr Date: 1996-02 Impact factor: 3.183